which classes of hyperlipoproteinaemia are best treated with a combination or with clofibrate alone. It is, however, quite clear that its greatest potential use is for the treatment of the type II pattern, which is, in general, affected little by clofibrate alone and only moderately by cholestyramine.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (1971) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: